Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Publications
»
Pioglitazone – New contra-indications and warnings following European review of bladder cancer risk
Your Selection
[x]
Product
: Human medicines
[x]
Document Type
: Safety Updates & Reports
[x] Remove All Filters
By Audience / Stakeholder Group
All Stakeholders (12)
Healthcare professionals (63)
Patients and consumers (1)
By Service
Clinical Trials (1)
Reporting Safety & Quality issues (1)
Pioglitazone – New contra-indications and warnings following European review of bladder cancer risk
05 September 2011
Tags:
Human medicines
Healthcare professionals
Safety Updates & Reports
2011
Pioglitazone – New contra-indications and warnings following European review of bladder cancer risk
« View Publications List
Provide Feedback
RSS Feeds
IMB Publications RSS Feed